AstraZeneca Announces Positive Phase III Top-line Results for PT003 from PINNACLE 1, PINNACLE 2 Studies in COPD
March 18, 2015 at 05:34 AM EDT
AstraZeneca (NYSE: AZN) today announced positive top-line results from the Phase III PINNACLE programme, which included two pivotal ...